Colgate-Palmolive (India) Reports Q4 FY26 Results and Declares Dividend

Colgate-Palmolive (India) Limited has announced its financial results for the quarter and year ended March 31, 2026, highlighting a 9% year-on-year topline growth for the fourth quarter. The company declared a second interim dividend of Rs. 24/- per share for the 2025-26 financial year. Additionally, the board approved the re-appointment of Mr. Jacob Sebastian Madukkakuzy as Whole-time Director and Chief Financial Officer for a five-year term.

Financial Performance Overview

For the quarter ended March 31, 2026 (Q4), the company reported a robust topline growth of 9%, with net sales increasing to Rs. 1,583 crore compared to Rs. 1,452 crore in the same period last year. For the full fiscal year 2025-26, the company recorded net sales of Rs. 5,984 crore, maintaining a steady performance level. Net profit after tax for the full year stood at Rs. 1,325 crore.

Strategic Growth Initiatives

Management noted that the sales momentum in Q4 was broad-based across core and premium portfolios. Investments in the strategic premium segment yielded significant results, growing at 3x the rate of the overall company. The organization continues to focus on its ‘Funding the Growth’ cost-saving initiatives while driving category consumption and accelerating premiumization in the oral care and personal care categories.

Dividend and Governance Updates

The Board of Directors has declared a Second Interim Dividend of Rs. 24/- per equity share of Re. 1/- face value. Including the previous dividend, the total payout for the year 2025-26 amounts to Rs. 48/- per share. The dividend is scheduled to be paid starting June 17, 2026, to shareholders of record as of June 1, 2026.

In leadership updates, the board approved the re-appointment of Mr. Jacob Sebastian Madukkakuzy as Whole-time Director and Chief Financial Officer, effective from October 28, 2026, through October 27, 2031, subject to shareholder approval.

Annual General Meeting

The company will convene its 85th Annual General Meeting on Wednesday, July 29, 2026. The meeting will be held via Video Conference/Other Audio-Visual Means to ensure accessibility for all shareholders.

Source: BSE

Previous Article

RHI Magnesita India Annual Secretarial Compliance Report for FY 2025-26

Next Article

Max Healthcare CCI Closes Abuse of Dominance Probe Against Network Hospitals